Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Synthetic BiologicsMedicureCrescita TherapeuticsbiOasis TechnologiesNaturally Splendid Enterprises
SymbolNYSEAMERICAN:SYNCVE:MPHTSE:CTXCVE:BTICVE:NSP
Price Information
Current Price$0.59N/AC$0.64C$0.32C$0.07
52 Week RangeBuyN/AN/AN/AN/A
Beat the Market™ Rank
Overall Score1.21.20.90.50.6
Analysis Score3.50.00.00.00.0
Community Score2.73.02.52.72.8
Dividend Score0.00.00.00.00.0
Ownership Score0.03.00.00.00.0
Earnings & Valuation Score0.00.01.90.00.0
Analyst Ratings
Consensus RecommendationBuyN/AN/AN/AN/A
Consensus Price Target$1.38N/AN/AN/AN/A
% Upside from Price Target134.24% upsideN/AN/AN/AN/A
Trade Information
Market Cap$10.64 millionC$10.80 millionC$13.01 millionC$10.16 millionC$11.06 million
BetaN/AN/AN/AN/AN/A
Average Volume436,83411,26339,14544,917678,956
Sales & Book Value
Annual RevenueN/AC$18.30 millionC$21.90 millionC$606,384.00C$2.98 million
Price / SalesN/A0.000.6035.814.32
CashflowN/AN/AC$0.58 per shareC$0.01 per shareC$0.00 per share
Price / CashN/A0.881.1048.7550.00
Book ValueN/AC$2.50 per shareC$1.00 per shareC($0.04) per shareC$0.00 per share
Price / BookN/A0.000.64-8.21-17.50
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AC($1.34)C$0.06C($0.07)C($0.06)
Trailing P/E Ratio0.00N/A10.16N/AN/A
Forward P/E Ratio∞N/A∞∞∞
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AC$2.02C$0.80
Dividend YieldN/AN/AN/A631.25%1,142.86%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/A N/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A3.85%7.15%N/A305.29%
Current RatioN/A2.57%3.44%0.26%0.47%
Quick RatioN/A1.78%2.59%0.24%0.06%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees13N/A62N/AN/A
Shares Outstanding19.44 million10.66 million20.65 million67.86 million184.30 million
Next Earnings DateN/A8/13/2020 (Estimated)N/A10/23/2020 (Estimated)N/A
OptionableNot OptionableNot OptionableNot OptionableOptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.